Haginin A is primarily studied for its potential biological activity, particularly in the field of natural product chemistry and drug discovery. It exhibits notable antioxidant properties, making it a candidate for research into cellular protection against oxidative stress. This compound has also shown inhibitory effects on certain enzymes, suggesting possible applications in managing metabolic disorders. Its structure supports interaction with biological targets involved in inflammation and aging-related pathways, which makes it of interest for pharmaceutical and cosmetic development. Ongoing studies focus on its bioavailability and efficacy in preclinical models.